Search by Drug Name or NDC

    NDC 24338-0851-10 Zenzedi 5 mg/1 Details

    Zenzedi 5 mg/1

    Zenzedi is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AZURITY PHARMACEUTICALS, INC.. The primary component is DEXTROAMPHETAMINE SULFATE.

    Product Information

    NDC 24338-0851
    Product ID 24338-851_ca930673-eecb-4c89-821f-c0dbd4b208b2
    Associated GPIs 61100020100305
    GCN Sequence Number 005011
    GCN Sequence Number Description dextroamphetamine sulfate TABLET 5 MG ORAL
    HIC3 J5B
    HIC3 Description ADRENERGICS, AROMATIC, NON-CATECHOLAMINE
    GCN 19881
    HICL Sequence Number 002065
    HICL Sequence Number Description DEXTROAMPHETAMINE SULFATE
    Brand/Generic Brand
    Proprietary Name Zenzedi
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextroamphetamine Sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name DEXTROAMPHETAMINE SULFATE
    Labeler Name AZURITY PHARMACEUTICALS, INC.
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA090533
    Listing Certified Through 2024-12-31

    Package

    NDC 24338-0851-10 (24338085110)

    NDC Package Code 24338-851-10
    Billing NDC 24338085110
    Package 100 TABLET in 1 BOTTLE (24338-851-10)
    Marketing Start Date 2013-05-31
    NDC Exclude Flag N
    Pricing Information N/A